Literature DB >> 32879752

Costs and Outcomes of Privately-Insured Kidney Transplant Recipients by Body Mass Index.

Patrick M Ercole1, Paula M Buchanan2, Krista L Lentine2,3, Thomas E Burroughs2, Mark A Schnitzler2, Kian A Modanlou4.   

Abstract

BACKGROUND: Obesity presents an additional challenge to the procedure of and recovery from kidney transplantation. As the prevalence of transplant candidates with an elevated body mass index (BMI) grows, researchers need to examine and quantify the increased risks and additional costs associated with the full spectrum of body composition. STUDY
DESIGN: A retrospective cohort study design was used. SETTING & PARTICIPANTS: Data from a private health insurance provider were linked with records from the Organ Procurement and Transplantation Network to examine costs and health outcomes following kidney transplantation. FACTOR: BMI was used to predict costs and outcomes. OUTCOMES: The primary outcome of interest was posttransplant cost defined as insurance charges. Secondary outcomes of interest included delayed graft function, graft failure, patient survival, and length of transplant hospitalization. MEASUREMENTS: Categories of BMI followed selected cutoffs from World Health Organization International Classifications. Charges from recipient dialysis center, health providers, and treatment centers following transplant were summed during transplant hospitalization as well as each of three years following transplantation.
RESULTS: Rates of graft failure were significantly increased for underweight, overweight, obese, and morbidly obese recipients. Recipients with elevated BMI had a significantly longer length of transplant hospitalization and an increased rate of delayed graft function. LIMITATIONS: Our analysis was limited to the quality and availability of the data included in the registry. Though inexpensive and easy to calculate, BMI may not be the best measure of body composition. Finally, BMI measurement is cross-sectional at time of transplant thereby limiting the potential for fluctuation of BMI before and after transplantation.
CONCLUSIONS: The study results highlight the exponential concern associated with non-normal BMI for kidney transplant recipients. Transplant centers and insurance companies should consider funding weight management programs for transplant candidates as a means of obtaining preferred BMI and reducing costs associated with follow-up care.

Entities:  

Keywords:  body mass index (BMI); cost; obesity; outcomes; renal; transplant

Year:  2012        PMID: 32879752      PMCID: PMC7462713          DOI: 10.4172/2161-0959.S4-003

Source DB:  PubMed          Journal:  J Nephrol Ther


  35 in total

1.  Renal function and healthcare costs in patients with polycystic kidney disease.

Authors:  Krista L Lentine; Huiling Xiao; Gerardo Machnicki; Adrian Gheorghian; Mark A Schnitzler
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 8.237

Review 2.  Obesity.

Authors:  David W Haslam; W Philip T James
Journal:  Lancet       Date:  2005-10-01       Impact factor: 79.321

Review 3.  Obesity and infection.

Authors:  Matthew E Falagas; Maria Kompoti
Journal:  Lancet Infect Dis       Date:  2006-07       Impact factor: 25.071

4.  Obesity and cardiac risk after kidney transplantation: experience at one center and comprehensive literature review.

Authors:  Krista L Lentine; Lisa A Rocca-Rey; Giuliana Bacchi; Nadia Wasi; Leslie Schmitz; Paolo R Salvalaggio; Kevin C Abbott; Mark A Schnitzler; Luca Neri; Daniel C Brennan
Journal:  Transplantation       Date:  2008-07-27       Impact factor: 4.939

5.  The association between length of post-kidney transplant hospitalization and long-term graft and recipient survival.

Authors:  Shih-jui Lin; James K Koford; Bradley C Baird; Arsalan N Habib; Ilya Reznik; Madhukar Chelamcharla; Fuad S Shihab; Alexander S Goldfarb-Rumyantzev
Journal:  Clin Transplant       Date:  2006 Mar-Apr       Impact factor: 2.863

6.  Racial variation in medical outcomes among living kidney donors.

Authors:  Krista L Lentine; Mark A Schnitzler; Huiling Xiao; Georges Saab; Paolo R Salvalaggio; David Axelrod; Connie L Davis; Kevin C Abbott; Daniel C Brennan
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

7.  Excess deaths associated with underweight, overweight, and obesity.

Authors:  Katherine M Flegal; Barry I Graubard; David F Williamson; Mitchell H Gail
Journal:  JAMA       Date:  2005-04-20       Impact factor: 56.272

8.  Impact of obesity on resource utilization for general surgical procedures.

Authors:  Mary T Hawn; John Bian; Ruth R Leeth; Gilbert Ritchie; Nechol Allen; Kirby I Bland; Selwyn M Vickers
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

9.  Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen.

Authors:  William Irish; Beth Sherrill; Daniel C Brennan; Jeffrey Lowell; Mark Schnitzler
Journal:  Transplantation       Date:  2003-12-27       Impact factor: 4.939

Review 10.  Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Gladys Block; Michael H Humphreys; Joel D Kopple
Journal:  Kidney Int       Date:  2003-03       Impact factor: 10.612

View more
  2 in total

1.  Machine Learning Consensus Clustering of Morbidly Obese Kidney Transplant Recipients in the United States.

Authors:  Charat Thongprayoon; Shennen A Mao; Caroline C Jadlowiec; Michael A Mao; Napat Leeaphorn; Wisit Kaewput; Pradeep Vaitla; Pattharawin Pattharanitima; Supawit Tangpanithandee; Pajaree Krisanapan; Fawad Qureshi; Pitchaphon Nissaisorakarn; Matthew Cooper; Wisit Cheungpasitporn
Journal:  J Clin Med       Date:  2022-06-08       Impact factor: 4.964

2.  Obesity as an isolated contraindication to kidney transplantation in the end-stage renal disease population: A cohort study.

Authors:  Babak J Orandi; Cora E Lewis; Paul A MacLennan; Haiyan Qu; Shikha Mehta; Vineeta Kumar; Saulat S Sheikh; Robert M Cannon; Douglas J Anderson; Michael J Hanaway; Rhiannon D Reed; A Cozette Killian; Joshua W Purvis; Norah A Terrault; Jayme E Locke
Journal:  Obesity (Silver Spring)       Date:  2021-08-02       Impact factor: 9.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.